Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ · Financial Services
Bellevue Life Sciences Acquisition Corp. Income Statement 2021–2023
| Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 0 | 0 | 0 |
| Gross Profit | — | — | — |
| Profitability | |||
| Operating Income | -1.8M | -35,388 | -3,308 |
| EBITDA | -1.8M | -35,388 | -3,308 |
| Net Income | 403,780 | -35,388 | -3,308 |
| Per Share Data | |||
| EPS (diluted) | $0.05 | $-0.00 | $-0.00 |
| Shares Outstanding (dil.) | 8M | 9M | 8M |
Bellevue Life Sciences Acquisition Corp. Income Statement — FAQ
Bellevue Life Sciences Acquisition Corp. (BLAC) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BLAC's income statement history?
The chart and table above show Bellevue Life Sciences Acquisition Corp.'s income statement by year and by quarter, including the growth rate.